GlassScriptPhysician profile
Matthew Pagano
NPI 1447540661
$2,092.15
in general payments reported to CMS, 2019-2025
13 companies · $237 in 2025
The $237 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $244 · 2020: $59.56 · 2021: $202 · 2022: $92.30 · 2023: $1,177 · 2024: $80.28 · 2025: $237.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $757 · Travel and Lodging: $737.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $757.34 |
| Travel and Lodging | $737.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $1,172.61 | 2022-2024 | Urolift |
| Coloplast Corp | $551.74 | 2019-2025 | |
| Boston Scientific Corporation | $158.72 | 2021-2024 | Lithovue, Tria Firm |
| Neotract INC. | $43.12 | 2019 | |
| Ferring Pharmaceuticals INC. | $27.22 | 2025 | Rebyota |
| Ambu INC. | $25.29 | 2020 | |
| Janssen Biotech, INC. | $22.10 | 2025 | Erleada |
| Lilly USA, LLC | $18.63 | 2020 | |
| Urogen Pharma, INC. | $17.00 | 2024 | |
| Rochester Medical Corporation | $15.78 | 2022 | |
| Myovant Sciences INC. | $14.54 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.14 | 2019 | |
| Olympus America INC. | $11.26 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Pagano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.